CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil”. This report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2012, Brazil’s population amounted to an estimated 198.4 million. The population is increasing steadily, which is largely due to a positive balance between the birth rate and the mortality rate. The country currently has a demographic advantage in terms of a large working age population, which increased in size from 2007 to 2012. The size of the elderly population – aged 65 years and older – is expected to increase in future to account for more than 9% of the population by 2020. The value of Brazil’s pharmaceutical market amounted to an estimated $23.8 billion in 2012 and is expected to have reached approximately $58.8 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 12%. The value of the medical device market amounted to approximately $7.9 billion in 2012 and is expected to reach approximately $13.1 billion in 2020 at a projected CAGR of 6.5%. These positive trends can primarily be attributed to -
- An increasing elderly population
- Healthcare coverage for 60–80% of the Brazilian population

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer Inc., Sanofi, Novartis and F. Hoffmann-La Roche Ltd. and AstraZeneca) and the medical device market (Siemens Healthcare, GE Healthcare, F. Hoffmann-La Roche, Essilor International, and Philips Healthcare)
- Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges facing growth in the Brazilian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Brazil’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Brazil’s healthcare market.

Table Of Contents

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 14
2 Introduction 19
2.1 GlobalData Report Guidance 19
3 Overview of the Pharmaceutical and Medical Devices Market 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Pharmaceutical Import and Export 23
3.1.3 Supply Channels 24
3.1.4 Market Segments 27
3.1.5 Major Disease Areas 32
3.1.6 Major Players 38
3.2 Medical Device Market 84
3.2.1 Market Overview 84
3.2.2 Overview of Leading Five Segments 87
3.2.3 Diagnostic Market 103
3.2.4 Major Players 105
3.3 Market Drivers and Barriers 138
3.3.1 Drivers 138
3.3.2 Barriers 139
4 Market Access 142
4.1 Overview of Healthcare System 142
4.1.1 Organizational structure 142
4.2 Reimbursement and Payer Landscape 145
4.2.1 Reimbursement Process 147
4.2.2 Pricing Procedure 150
4.2.3 Overview of Insurance Providers 153
4.2.4 Patient Share in Healthcare Spending 160
4.2.5 Drug Price Trend 161
4.2.6 Pricing Policies 162
4.3 Regulatory Landscape 164
4.3.1 Overview of Regulatory Agencies 164
4.3.2 New Drug Approval Process 172
4.3.3 Generic Drug Approval Process 176
4.3.4 New Medical Device Approval Process 179
4.3.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 183
4.3.6 Licensing Process for Pharmaceutical Exports and Imports 184
4.3.7 Intellectual Property Rights 186
4.3.8 Clinical Trial Regulations 191
4.3.9 Pharmaceutical Advertising Regulations 193
4.3.10 Pharmacy Regulations 193
4.3.11 Labeling and Packaging Regulations 195
5 Country Analysis 197
5.1 Political Environment 197
5.1.1 Political Structure 197
5.1.2 Analysis of Current Political Environment 198
5.1.3 Healthcare Policy Initiatives 200
5.2 Economic Landscape 206
5.3 Economic Indicators 211
5.3.1 Gross Domestic Product 211
5.3.2 Gross National Income 216
5.3.3 Inflation 217
5.3.4 Currency Exchange Rate 220
5.3.5 Foreign Direct Investment 221
5.3.6 Foreign Exchange Reserves 222
5.3.7 Trade Balance 223
5.3.8 Government Structural Balance 226
5.3.9 Government Net Debt 227
5.3.10 Major Industries 228
5.4 Demography 230
5.4.1 Population 230
5.4.2 Education and Literacy 247
5.4.3 Employment 249
5.4.4 Disease Burden 250
5.5 Healthcare Infrastructure 253
5.5.1 Healthcare Facilities 254
5.5.2 Healthcare Parameters 261
5.5.3 Environmental Health 263
5.5.4 Healthcare Personnel 271
5.6 Healthcare Expenditure 273
5.6.1 Overview 273
5.6.2 Major Components of Healthcare Spending 274
5.6.3 Share of Public and Private Sectors 277
5.6.4 Spending on Pharmaceutical RandD 278
5.7 Trade Associations 279
5.7.1 ABIMO 279
5.7.2 ABIMED 279
5.7.3 Interfarma 280
5.7.4 Abiquifi 280
5.8 Trade Fairs 281
6 Opportunities and Challenges 282
6.1 Opportunities 282
6.2 Challenges 283
7 Appendix 285
7.1 Abbreviations 285
7.2 Bibliography 298
7.3 Methodology 317
7.3.1 Coverage 317
7.3.2 Secondary Research 318
7.3.3 Forecasting 318
7.3.4 Expert Panel Validation 318
7.4 Disclaimer 319

1.1 List of Tables
Table 1: Pharmaceutical Industry, Brazil, Revenue ($bn), 2007-2012 21
Table 2: Pharmaceutical Market, Brazil, Revenue ($bn), Forecast, 2013-2020 22
Table 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2007-2012 23
Table 4: Pharmaceutical Market, Brazil, Margin of Preference For Drugs And Medications, 2013 26
Table 5: Pharmaceutical Market, Brazil, Product Development Partnerships of Biologics, 2013 30
Table 6: Pharmaceutical Market, Brazil, Proportional Distribution of Types of Cancer by Incidence, 2012 33
Table 7: Pharmaceutical Market, Brazil, Mortality by Type of Cancer (%), 2010 34
Table 8: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2010 37
Table 9: Pfizer, Global, Major Products, Revenue ($m), 2012 39
Table 10: Pfizer, Global, Late-stage Pipeline, 2013 39
Table 11: Novartis, Global, Major Products, Revenue ($m), 2012 50
Table 12: Novartis, Global, Planned Filings, 2012-2016 51
Table 13: Sanofi, Global, Major Products, Revenue ($bn), 2012 58
Table 14: Sanofi, Global, Late-stage Pipeline, 2013 59
Table 15: Roche, Global, Major Products, Revenue ($bn), 2012 65
Table 16: Roche, Global, Late-stage Pipeline, 2013 66
Table 17: AstraZeneca, Global, Major Products, Revenue ($bn), 2011 73
Table 18: AstraZeneca, Global, Late-stage Pipeline, 2012 74
Table 19: Medical Device Market, Brazil, Revenue ($bn), 2007-2012 85
Table 20: Medical Device Market, Brazil, Revenue Forecast ($bn), 2013-2020 86
Table 21: Medical Device Market, Brazil, Revenue by Segment ($bn), 2012 87
Table 22: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2007-2012 89
Table 23: Medical Device Market, Brazil, Sales Trend for Major Players*, Ophthalmic Devices, 2011 90
Table 24: Medical Device Market, Brazil, In-Vitro Diagnostics Market, Revenue ($bn), 2007-2012 92
Table 25: Medical Device Market, Brazil, Sales Trend for Major Players*, In-Vitro Diagnostic Devices, 2011 93
Table 26: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2007-2012 95
Table 27: Medical Device Market, Brazil, Sales Trends for Major Players*, Diagnostic Imaging Devices, 2011 96
Table 28: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2007-2012 98
Table 29: Medical Device Market, Brazil, Sales Trend for Major Players*, Orthopedic Devices, 2011 99
Table 30: Medical Device Market, Brazil, Cardiovascular Devices Market, Revenue ($bn), 2007-2012 101
Table 31: Medical Device Market, Brazil, Sales Trend for Major Players*, Cardiovascular Devices, 2011 102
Table 32: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), 2007-2012 103
Table 33: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), Forecast, 2013-2020 104
Table 34: Medical Device Market, Brazil, Major Medical Device Companies, Revenue ($m), 2011 105
Table 35: Siemens, Global, Major Products, Revenue ($m), 2012 106
Table 36: Roche, Global, Major Products, Revenue ($m), 2012 118
Table 37: Essilor International, Global, Major Segments, Revenue ($m), 2011 125
Table 38: Philips Healthcare, Global, Major Products, Revenue ($bn), 2012 131
Table 39: Healthcare System, Brazil, 2013 142
Table 40: Healthcare System, Brazil, Comparative Analysis of CITEC and CONITEC, 2013 148
Table 41: Healthcare System, Brazil, Mean Reduction in Factory Price and Number of Products (%), 2004-2011 153
Table 42: Healthcare Spending, Brazil, Decision-Making Structure of SUS, 2013 155
Table 43: Healthcare Spending, Brazil, Distribution of Health Insurance Beneficiaries (%), 2013 156
Table 44: Healthcare Spending, Brazil, Private Health Insurance Beneficiaries (million), 2007-2012 157
Table 45: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2007-2012 160
Table 46: Price of Drugs, Brazil, Change in Average Price of Prescription (%), 2007-2011 161
Table 47: Pricing Policies, Brazil, 2013 163
Table 48: Healthcare System, Brazil, Documents Required for Dossier Submission of Clinical Trial, 2013 192
Table 49: Economic Landscape, Brazil, BRICS Comparison, 2012 208
Table 50: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), 2007-2012 212
Table 51: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), Forecast, 2013-2020 212
Table 52: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), 2007-2012 213
Table 53: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), Forecast, 2013-2020 214
Table 54: Economic Indicators, Brazil, Gross Domestic Product, Brazil, Russia, India, China, Annual Growth (%), 2007-2012 215
Table 55: Economic Indicators, Brazil, Gross National Income Per Capita ($), 2007-2012 216
Table 56: Economic Indicators, Brazil, Average Consumer Price Index, 2007-2012 218
Table 57: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2007-2012 219
Table 58: Economic Indicators, Brazil, Currency Exchange Rate ($/BRL), 2007-2012 220
Table 59: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2007-2012 221
Table 60: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2007-2012 222
Table 61: Economic Indicators, Brazil, Trade Balance ($bn), 2007-2012 223
Table 62: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2007-2012 224
Table 63: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2007-2012 225
Table 64: Economic Indicators, Brazil, General Government Structural Balance ($bn), 2007-2012 226
Table 65: Economic Indicators, Brazil, General Government Net Debt ($bn), 2007-2012 227
Table 66: Economic Indicators, Brazil, Major Industries by Contribution to GDP (%), 2011 229
Table 67: Demographics, Brazil, Population (million), 2007-2012 230
Table 68: Demographics, Brazil, Population (million), Forecast, 2013-2020 231
Table 69: Demographics, Brazil, Urban and Rural Population Share (%), 2007-2012 233
Table 70: Demographics, Brazil, Urban and Rural Population Share (%), Forecast, 2013-2020 234
Table 71: Demographics, Brazil, Population Distribution by Age Group (%), 2007-2012 236
Table 72: Demographics, Brazil, Population Distribution by Age Group (%), Forecast, 2013-2020 236
Table 73: Demographics, Brazil, (Per 1,000 Population), 2007-2012 238
Table 74: Demographics, Brazil, Mortality (Per 1,000 Population), 2007-2012 238
Table 75: Demographics, Brazil, Major Causes of Mortality (‘000), 2010 240
Table 76: Demographics, Brazil, Children Table 77: Demographics, Brazil, Immunization Rate (%), 2007-2012 242
Table 78: Demographics, Brazil, Major Causes of Mortality per 100,000 Population, 2010 244
Table 79: Demographics, Brazil, Gender Ratio (M/F), 2007-2012 245
Table 80: Demographics, Brazil, Life Expectancy at Birth (Years), 2007-2012 246
Table 81: Demographics, Brazil, Illiteracy (%), 2007-2012 248
Table 82: Demographics, Brazil, Employment Rate (%), 2007-2012 250
Table 83: Demographics, Brazil, Major Diseases, DALY (Per 100,000 Population), 2004 251
Table 84: Demographics, Brazil, Major Diseases, In Patients, Jan 2013-May 2013 252
Table 85: Healthcare Infrastructure, Brazil, Total Number of Hospitals, 2012 254
Table 86: Healthcare Infrastructure, Brazil, Hospitals Linked to SUS (%), 2013 255
Table 87: Healthcare Infrastructure, Brazil, Hospital Beds (‘000), 2012 256
Table 88: Healthcare Infrastructure, Brazil, Hospital Beds by Type of Service (‘000), 2013 256
Table 89: Healthcare Infrastructure, Brazil, Hospitals Beds by Type of Care (‘000), 2012 257
Table 90: Healthcare Infrastructure, Brazil, SUS ICU Beds by Type, 2013 258
Table 91: Healthcare Infrastructure, Brazil, Complementary Services (‘000), 2013 259
Table 92: Healthcare Infrastructure, Brazil, Number of Items of Equipment (‘000), 2013 260
Table 93: Healthcare Infrastructure, Brazil, Beds (Per 1,000 Population), 2007-2012 261
Table 94: Healthcare Infrastructure, Brazil, Physicians (per 1,000 Population), 2007-2012 262
Table 95: Environmental Health, Brazil, Targets for Carbon Reduction, 2009 264
Table 96: Environmental Health, Brazil, PM10 Emissions (?g/m3), 2007-2012 265
Table 97: Environmental Health, Brazil, N2O Emissions (’000 metric tons), 2007-2012 266
Table 98: Environmental Health, Brazil, CO2 Emissions (kilotons), 2007-2012 267
Table 99: Environmental Health, Brazil, Other Greenhouse Gas Emissions (‘000 metric tons), 2007-2012 269
Table 100: Environmental Health, Brazil, Proportion of the Population Using Improved Drinking Water Sources (%), 2007-2012 270
Table 101: Healthcare Personnel, Brazil, Healthcare Personnel (’000), 2013 272
Table 102: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2007-2012 273
Table 103: Healthcare Expenditure, Brazil, Household Healthcare Expenditure, Share (%), 2009 275
Table 104: Healthcare Expenditure, Brazil, General Government Healthcare Expenditure, Share (%), 2009 276
Table 105: Healthcare Expenditure, Brazil, Health Expenditure, Public-Private Share (%), 2007-2012 277
Table 106: Healthcare Expenditure, Brazil, Pharmaceutical RandD Expenditure, Share (%), 2008 278
Table 107: Healthcare Expenditure, Brazil, Biopharmaceutical RandD Financing in China, India, Brazil and South Africa, 2013 279
Table 108: Major Healthcare Trade Fairs, Brazil, 2013 281

1.2 List of Figures
Figure 1: Pharmaceutical Industry, Brazil, Revenue ($bn), 2007-2012 21
Figure 2: Pharmaceutical Market, Brazil, Revenue ($bn), Forecast, 2013-2020 22
Figure 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2007-2012 23
Figure 4: Pharmaceutical Market, Brazil, Pharmaceutical Distribution Channel, 2013 25
Figure 5: Pharmaceutical Market, Brazil, Mortality by Type of Cancer (%), 2010 34
Figure 6: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2010 37
Figure 7: Medical Device Market, Brazil, Revenue ($bn), 2007-2012 85
Figure 8: Medical Device Market, Brazil, Revenue Forecast ($bn), 2013-2020 86
Figure 9: Medical Device Market, Brazil, Revenue by Segment ($bn), 2012 87
Figure 10: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2007-2012 89
Figure 11: Medical Device Market, Brazil, Sales Trends for Major Players*, Ophthalmic Devices, 2007-2011 90
Figure 12: Medical Device Market, Brazil, In-Vitro Diagnostics Market, Revenue ($bn), 2007-2012 92
Figure 13: Medical Device Market, Brazil, Sales Trend for Major Players*, In-Vitro Diagnostic Devices, 2007-2011 93
Figure 14: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2007-2012 95
Figure 15: Medical Device Market, Brazil, Sales Trends for Major Players*, Diagnostic Imaging Devices, 2007-2011 96
Figure 16: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2007-2012 98
Figure 17: Medical Device Market, Brazil, Sales Trend for Major Players*, Orthopedic Devices, 2007-2011 99
Figure 18: Medical Device Market, Brazil, Cardiovascular Devices Market, Revenue ($bn), 2007-2012 101
Figure 19: Medical Device Market, Brazil, Sales Trend for Major Players*, Cardiovascular Devices, 2007-2011 102
Figure 20: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), 2007-2012 103
Figure 21: Medical Device Market, Brazil, Diagnostics Market, Revenue ($bn), Forecast, 2013-2020 104
Figure 22: Medical Device Market, Brazil, Major Medical Device Companies, Revenue ($m), 2011 105
Figure 23: Healthcare Market, Brazil, Drivers and Barriers, 2013 141
Figure 24: Healthcare System, Brazil, Financing Flows, 2013 144
Figure 25: Healthcare System, Brazil, Reimbursement System, 2013 147
Figure 26: Healthcare System, Brazil, Reimbursement Process, 2013 150
Figure 27: Healthcare System, Brazil, Flowchart for Classification of Drugs into Categories, 2013 152
Figure 28: Healthcare Spending, Brazil, Health Insurance Providers, 2013 154
Figure 29: Healthcare Spending, Brazil, Distribution of Health Insurance Beneficiaries (%), 2013 155
Figure 30: Healthcare Spending, Brazil, Private Health Insurance Beneficiaries (million), 2007-2012 156
Figure 31: Healthcare System, Brazil, Organization Structure of ANS, 2013 158
Figure 32: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2007-2012 160
Figure 33: Price of Drugs, Brazil, Change in Average Price of Drugs (%), 2007-2011 161
Figure 34: Healthcare System, Brazil, Ministry of Health Organizational Structure, 2013 166
Figure 35: Healthcare System, Brazil, ANVISA Old Organizational Structure, 2013 168
Figure 36: Healthcare System, Brazil, Roles and Responsibilities of Regulatory Bodies, 2013 172
Figure 37: Healthcare System, Brazil, New Drug Approval Stages, 2013 173
Figure 38: Healthcare System, Brazil, New Drug Approval Process, 2013 175
Figure 39: Healthcare System, Brazil, Generic Drug Approval Process, 2013 177
Figure 40: Healthcare System, Brazil, Similar Drug (Biosimilar) Approval Process, 2013 178
Figure 41: Healthcare System, Brazil, New Medical Device Approval Process, 2013 180
Figure 42: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), 2007-2012 211
Figure 43: Economic Indicators, Brazil, Gross Domestic Product Per Capita ($), Forecast, 2013-2020 212
Figure 44: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), 2007-2012 213
Figure 45: Economic Indicators, Brazil, Gross Domestic Product Annual Growth (%), Forecast, 2013-2020 214
Figure 46: Economic Indicators, Brazil, Gross National Income Per Capita ($), 2007-2012 216
Figure 47: Economic Indicators, Brazil, Average Consumer Price Index, 2007-2012 218
Figure 48: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2007-2012 219
Figure 49: Economic Indicators, Brazil, Currency Exchange Rate ($/BRL), 2007-2012 220
Figure 50: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2007-2012 221
Figure 51: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2007-2012 222
Figure 52: Economic Indicators, Brazil, Trade Balance ($bn), 2007-2012 223
Figure 53: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2007-2012 224
Figure 54: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2007-2012 225
Figure 55: Economic Indicators, Brazil, General Government Structural Balance ($bn), 2007-2012 226
Figure 56: Economic Indicators, Brazil, General Government Net Debt ($bn), 2007-2012 227
Figure 57: Economic Indicators, Brazil, Major Industries by % Contribution to GDP, 2011 228
Figure 58: Demographics, Brazil, Population (million), 2007-2012 230
Figure 59: Demographics, Brazil, Population (million), Forecast, 2013-2020 231
Figure 60: Demographics, Brazil, Urban and Rural Population Share (%), 2007-2012 233
Figure 61: Demographics, Brazil, Urban and Rural Population Share (%), Forecast, 2013-2020 234
Figure 62: Demographics, Brazil, Population Distribution by Age Group (%), 2007-2012 235
Figure 63: Demographics, Brazil, Population Distribution by Age Group (%), Forecast, 2013-2020 236
Figure 64: Demographics, Brazil, Births (Per 1,000 Population), 2007-2012 237
Figure 65: Demographics, Brazil, Mortality (Per 1,000 Population), 2007-2012 238
Figure 66: Demographics, Brazil, Major Causes of Mortality (‘000), 2010 239
Figure 67: Demographics, Brazil, Children Figure 68: Demographics, Brazil, Immunization Rate (%), 2007-2012 242
Figure 69: Demographics, Brazil, Major Causes of Mortality per 100,000 Population, 2010 243
Figure 70: Demographics, Brazil, Gender Ratio (M/F), 2007-2012 245
Figure 71: Demographics, Brazil, Life Expectancy at Birth (Years), 2007-2012 246
Figure 72: Demographics, Brazil, Illiteracy (%), 2007-2012 248
Figure 73: Demographics, Brazil, Employment Rate (%), 2007-2012 249
Figure 74: Demographics, Brazil, Major Diseases, DALY (Per 100,000 Population), 2004 250
Figure 75: Healthcare Infrastructure, Brazil, Flow of Funds to Hospitals, 2008 253
Figure 76: Healthcare Infrastructure, Brazil, Hospitals Linked to SUS (%), 2013 254
Figure 77: Healthcare Infrastructure, Brazil, Hospital Beds (‘000), 2007-2012 255
Figure 78: Healthcare Infrastructure, Brazil, Hospital Beds by Type of Service (‘000), 2013 256
Figure 79: Healthcare Infrastructure, Brazil, Hospitals Beds by Type of Care (‘000), 2012 257
Figure 80: Healthcare Infrastructure, Brazil, SUS ICU Beds by Type, 2013 258
Figure 81: Healthcare Infrastructure, Brazil, Complementary Services (‘000), 2013 259
Figure 82: Healthcare Infrastructure, Brazil, Number of Items of Equipment (‘000), 2013 260
Figure 83: Healthcare Infrastructure, Brazil, Beds (Per 1,000 Population), 2007-2012 261
Figure 84: Healthcare Infrastructure, Brazil, Physicians (per 1,000 Population), 2007-2012 262
Figure 85: Environmental Health, Brazil, PM10 Emissions (?g/m3), 2007-2012 265
Figure 86: Environmental Health, Brazil, N2O Emissions (‘000 metric tons), 2007-2012 266
Figure 87: Environmental Health, Brazil, CO2Emissions (kilotons), 2007-2012 267
Figure 88: Environmental Health, Brazil, Other Greenhouse Gas Emissions (‘000 metric tons), 2007-2012 269
Figure 89: Environmental Health, Brazil, Proportion of the Population Using Improved Drinking Water Sources (%), 2007-2012 270
Figure 90: Healthcare Personnel, Brazil, Healthcare Personnel (’000), 2013 271
Figure 91: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2007-2012 273
Figure 92: Healthcare Expenditure, Brazil, Household Healthcare Expenditure, Share (%), 2009 274
Figure 93: Healthcare Expenditure, Brazil, General Government Healthcare Expenditure, Share (%), 2009 276
Figure 94: Healthcare Expenditure, Brazil, Health Expenditure, Public-Private Share (%), 2007-2012 277
Figure 95: Healthcare Expenditure, Brazil, Pharmaceutical RandD Expenditure, Components Share (%), 2008 278
Figure 96: Healthcare Market, Brazil, Opportunities and Challenges, 2013 284

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.